• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Suction Cup Delivers Drugs Through Cheek

      Suction Cup Delivers Drugs Through Cheek

    • Radiology
      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

    • Cardiology
      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

    • Surgery
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Stretchable E-Skin for Robotic Prostheses

      Stretchable E-Skin for Robotic Prostheses

      Glasses Provide Audible Prompts for Blind Wearers

      Glasses Provide Audible Prompts for Blind Wearers

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      Robotic Ankle Helps with Postural Control in Amputees

      Robotic Ankle Helps with Postural Control in Amputees

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Retinitis Pigmentosa Pipeline Booms as 45+ Therapies Likely to Enter the Treatment Domain | Major Companies- Biogen, Novartis Pharmaceuticals, and Others.

March 1st, 2023 DelveInsight Business Research Releases

DelveInsight’s “Retinitis Pigmentosa Pipeline Insight 2023” report provides comprehensive global Retinitis Pigmentosa coverage of available, marketed, and Retinitis Pigmentosa Pipeline therapies in various stages of Retinitis Pigmentosa clinical trials development, major pharmaceutical Retinitis Pigmentosa Companies are working to advance the Retinitis Pigmentosa pipeline space and future growth potential of the Retinitis Pigmentosa pipeline domain.

For Retinitis Pigmentosa Emerging Drugs, the Retinitis Pigmentosa Pipeline analysis report provides a 360° view of the Retinitis Pigmentosa pipeline therapeutics landscape by development point, product type, route of administration, molecule type, and MOA. The Retinitis Pigmentosa pipeline research covers business opportunities, challenges, future partnerships, strong competitors, and growth strategies.

Key takeaways from the Retinitis Pigmentosa Pipeline Report

  • Over 45+ Retinitis Pigmentosa companies are evaluating 45+ Retinitis Pigmentosa pipeline therapies in various stages of development, and their anticipated acceptance in the Retinitis Pigmentosa market would significantly increase market revenue.
  • The leading Retinitis Pigmentosa Companies includes Biogen, Neurotech, Ionis Pharmaceuticals, Novartis Pharmaceuticals, Nacuity Pharmaceuticals, ReNeuron, ID Pharma, Allegro Ophthalmics, SparingVision, Editas Medicine, OiDE OptoEye, and others.
  • Promising Retinitis Pigmentosa Pipeline Therapies includes AAV2/5-RPGR, CPK850, Ophthalmic examinations, Mobility Test, NT-501, RST-001, and others.
  • The Retinitis Pigmentosa Companies and academics are working to assess challenges and seek opportunities that could influence Retinitis Pigmentosa R&D. The Retinitis Pigmentosa pipeline therapies under development are focused on novel approaches to treat/improve Retinitis Pigmentosa.
  • In November 2019, ProQR Therapeutics announced that it received Orphan Drug designation (ODD) from the Food and Drug Administration (FDA) for QR-1123. QR-1123 was in-licensed from Ionis Pharmaceuticals in 2018. QR-1123 has also received Fast Track designation from the FDA.

Request a sample and discover the recent breakthroughs happening in Retinitis Pigmentosa Pipeline Landscape @ Retinitis Pigmentosa Pipeline Outlook Report

Retinitis Pigmentosa Overview

Retinitis pigmentosa (RP) is an umbrella term for a group of hereditary progressive retinal disorders that cause progressive degeneration of the retina. The disease is inherited as autosomal recessive, autosomal dominant or X-linked recessive traits. Signs of retinitis pigmentosa usually appear during childhood or adolescence. Common symptoms include difficulty seeing at night and a loss of side (peripheral) vision. RP is diagnosed by electroretinography (ERG), visual field testing, and retinal imaging, fundus auto-fluorescence (FAF) and genetic testing. Currently, there is no therapy that stops the evolution of pigmentary retinopathies or restores the vision. Management of retinitis pigmentosa includes dietary supplements, ozone therapy, surgery etc. Gene therapy based treatments are under research focus for the treatment of Retinitis pigmentosa.

Retinitis Pigmentosa Emerging Drugs Profile

  • BIIB-112: Biogen

BIIB-112 (formerly called NSR-RPGR) consists of a standard AAV8 vector carrying a codon optimized RPGR gene. BIIB112 is in phase II clinical studies for X-linked retinitis pigmentosa treatment. In September 2018, NSR-RPGR was granted orphan drug designation for the treatment of inherited retinal dystrophies due to defects in the RPGR gene from the U.S. Food and Drug Administration.

  • QR 1123 (formerly ISIS RHO 2.5Rx): Ionis Pharmaceuticals

QR 1123 (formerly ISIS RHO 2.5Rx) is an antisense oligonucleotide, designed to specifically target the mutant P23H messenger ribonucleic acid (mRNA) in order to reduce the expression of the P23H protein selectively, while preserving expression of the wild type (WT) rhodopsin (RHO) protein. The therapy is currently in Phase II clinical evaluation for the treatment of Retinitis Pigmentosa. In November 2019, ProQR Therapeutics announced that it received Orphan Drug designation (ODD) from the Food and Drug Administration (FDA) for QR-1123. QR-1123 was in-licensed from Ionis Pharmaceuticals in 2018. QR-1123 has also received Fast Track designation from the FDA.

Find out more about the Retinitis Pigmentosa Diagnosis and Treatment of patients @ Retinitis Pigmentosa Ongoing Clinical Trials Analysis

Retinitis Pigmentosa Companies and Pipeline Therapies

  • Biogen: AAV2/5-RPGR
  • Neurotech: CPK850
  • Ionis Pharmaceuticals: Ophthalmic examinations
  • Nacuity Pharmaceuticals: Mobility Test
  • Allegro Ophthalmics: NT-501
  • ID Pharma: RST-001

Retinitis Pigmentosa Pipeline Therapeutics Assessment

Phases

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

Route of Administration

  • Oral
  • Parenteral
  • Intravitreal
  • Subretinal
  • Topical

Molecule Type

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

Discover more about the list of Retinitis Pigmentosa FDA-approved drugs for Retinitis Pigmentosa @ Retinitis Pigmentosa Treatment Landscape

Scope of the Retinitis Pigmentosa Pipeline Report

  • Coverage- Global
  • Retinitis Pigmentosa Companies- Biogen (NYSE: BIIB), Neurotech International Inc (NYSE: NTI), Ionis Pharmaceuticals (NYSE: IONS), Novartis Pharmaceuticals (NYSE: NVS), Nacuity Pharmaceuticals, ReNeuron Group Inc (NYSE: RNUGF), ID Pharma, Allegro Ophthalmics, SparingVision, Editas Medicine (NYSE: EDIT), OiDE OptoEye, and others
  • Retinitis Pigmentosa Pipeline Therapies- AAV2/5-RPGR, CPK850, Ophthalmic examinations, Mobility Test, NT-501, RST-001, and others.
  • Retinitis Pigmentosa Pipeline Segmentation: Product Type, Molecule Type, Route of Administration, Mechanism of Action

Dive deep into rich insights for Retinitis Pigmentosa Emerging Therapies and Ongoing Clinical Trials; visit @ Retinitis Pigmentosa Emerging Therapies and Companies

Table of Content

  1. Introduction
  2. Retinitis Pigmentosa Executive Summary
  3. Retinitis Pigmentosa: Overview
  4. Retinitis Pigmentosa Pipeline Therapeutics
  5. Retinitis Pigmentosa Therapeutic Assessment
  6. Retinitis Pigmentosa – DelveInsight’s Analytical Perspective
  7. In-depth Commercial Assessment
  8. Retinitis Pigmentosa Collaboration Deals
  9. Late Stage Products (Phase III)
  10. Drug name: Company name
  11. Drug profiles in the detailed report…..
  12. Mid Stage Products (Phase II)
  13. BIIB-112: Biogen
  14. Drug profiles in the detailed report…..
  15. Early Stage Products (Phase I) 
  16. N-acetylcysteine-amide: Nacuity Pharmaceuticals
  17. Drug profiles in the detailed report…..
  18. Preclinical and Discovery Stage Products
  19. SPVN 06: SparingVision
  20. Drug profiles in the detailed report…..
  21. Inactive Products
  22. Retinitis Pigmentosa Key Companies
  23. Retinitis Pigmentosa Key Products
  24. Retinitis Pigmentosa- Unmet Needs
  25. Retinitis Pigmentosa- Market Drivers and Barriers
  26. Retinitis Pigmentosa- Future Perspectives and Conclusion
  27. Retinitis Pigmentosa Analyst Views
  28. Retinitis Pigmentosa Key Companies
  29. Appendix

For further information on the Retinitis Pigmentosa Pipeline therapeutics, reach out @ Retinitis Pigmentosa Market Drivers and Barriers

Latest Pharmaceuticals Market Research Reports in 2023

Trichotillomania market | Myopia progression market | Temporomandibular disorders market | Immune thrombocytopenia market | Spondylolisthesis market | Supraventricular tachycardia market | Tay-sachs disease market | Varicella zoster HHV 3 infections market | X-linked retinitis Pigmentosa market | Progressive Supranuclear palsy market report | Sly syndrome Market | Erosive hand osteoarthritis market |Coronary stents pipeline | Bone Anchored Hearing Systems Market | Adrenocortical Carcinoma Market | Hip Replacement Devices Market | Dermal Erythema Market | Acoustic Neuroma Market | Meningioma Market | Bronchial Spasm Market | Age Related Vision Dysfunction Market

Published Healthcare Blogs by DelveInsight

  • Biologics Spark Market Interest In The Nasal Polyposis Treatment Space
  • Biochips: An Evolving Technology Driving the Future of Healthcare Market

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Healthcare Market Research Reports, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash Bhardwaj

info@delveinsight.com

Healthcare Market Research Reports | Healthcare Consulting

Sign up and submit a press release

Sponsored
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

PACKAGING COMPLIANCE LABS WELCOMES NEW CFO, BERNADETTE LEGARETTA

PACKAGING COMPLIANCE LABS WELCOMES JENN GOFF, VP SALES, MARKETING, AND INNOVATION

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

interviews & reviews
A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

Eko’s Newest CORE 500 Stethoscope: A Review

Eko’s Newest CORE 500 Stethoscope: A Review

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!